MEDICAL GLASS ELEMENT

DE502016016778D1Active Publication Date: 2024-11-28SCHOTT AG
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
DE502016016778
Authority / Receiving Office
DE · DE
Patent Type
Patents
Current Assignee / Owner
Priority Date
2015-09-22
Filing Date
2016-09-06
Publication Date
2024-11-28
Estimated Expiration
2036-09-06

AI Technical Summary

Technical Problem

Medical devices and implants are susceptible to biofilm formation, which leads to infections and is resistant to environmental and antibiotic treatments, posing a significant challenge in hygiene and safety.

Method used

A glass composition with specific oxide ratios, including SiO2, ZnO, and other oxides, is used to inhibit biofilm formation and promote compatibility with human or animal cells, reducing cytotoxicity and hemolysis, and enhancing biofilm porosity and reduced thickness.

Benefits of technology

The glass composition effectively reduces biofilm attachment and thickness, while being non-cytotoxic and hemocompatible, offering improved hygiene and safety for medical devices and implants.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art

Description

[0001] The invention relates to an element which can be introduced into the human or animal body and which comprises a glass at least in some areas.

[0002] Biofilms are complex communities of microorganisms in nutrient-rich aqueous systems. Their formation is associated with the adhesion and colonization of surfaces through the production of sticky extracellular polymers. Biofilm formation is also referred to as microfouling and is the first step in macrofouling, i.e., the colonization or development of macroscopic fouling organisms.

[0003] In the medical field, components permanently in or on the body, such as catheters, prostheses, artificial heart valves, implants, pacemakers, and so on, are extremely susceptible to microfouling. This carries the risk of biofilm-associated diseases and infections.

[0004] Biofilms are largely resistant to environmental factors such as ultraviolet radiation and to chemical treatments such as detergents, i.e., surfactants. Furthermore, biofilms are hardly responsive to antibiotics and are protected against the host's immune system. It is estimated that S . aureus and S . epidermidis cause approximately 40% to 50% of infections in artificial heart valves and between approximately 50% and 70% of biofilm infections in catheters.

[0005] The US patent application US 2012 / 0219792 A1 relates to a glass substrate for a display cover with excellent strength, antibacterial properties, high transparency and high transmission in the visible light range.

[0006] The international patent application WO 2004 / 076369 A1 describes an antimicrobial borosilicate glass.

[0007] DE 101 20 475 A1 describes a borosilicate glass with a low processing temperature.

[0008] DE 10 2004 023 732 A1 describes the use of silicon-containing and phosphorus-free glasses for the treatment of inflammatory diseases.

[0009] Finally, US patent application US 2007 / 0172661 A1 concerns antimicrobial glass and glass-ceramic surfaces and their production.

[0010] It is an object of the invention to provide a material which is less colonized by biofilms than known materials for elements which can be attached or introduced into the human or animal body.

[0011] It is a further object of the invention to provide a material which is also well tolerated by the body.

[0012] These objects are already achieved in a highly surprising manner for the person skilled in the art with an element which can be introduced into the human or animal body, wherein the element is selected from the group comprising housings for electronic devices such as transponders, defibrillators, pacemakers and which has at least in some regions a glass which inhibits the formation of biofilms and / or is non-cytotoxic to human or animal cells and is compatible with blood when the element is introduced into the human or animal body or attached to it, wherein the glass at least SiO2 in the range of 60 to 75 wt% and ZnO in the range of 1 to 7 wt.% wherein the element comprises at least one housing or is a housing which is designed to accommodate electronic components, wherein the housing consists at least partially of the glass and / or wherein the housing has at least one layer of the glass at least partially.

[0013] It is advantageous if the element inhibits the formation of biofilms. Alternatively, it is possible and equally advantageous for human or animal cells to adhere to the element when it is introduced into or attached to the human or animal body.

[0014] It is particularly advantageous if the element inhibits the formation of biofilms and if human or animal cells adhere to the element when it is introduced into or attached to the human or animal body. All of these properties are encompassed by the invention.

[0015] The inventors have discovered that, surprisingly, the glass inhibits the formation of biofilms and that human or animal cells advantageously adhere to the glass when the element is introduced into the human or animal body. According to the inventors' findings, eukaryotic and prokaryotic cells react in opposite ways to glass with the composition according to the invention. The invention utilizes this by using the glass for components that come into contact with the human or animal body, particularly those that are introduced into those bodies where high hygiene requirements apply. According to the invention, the same material enables, on the one hand, the inhibition of biofilm formation and, on the other hand, compatibility, even to the point of ingrowth or integration into (or attachment to) the body cells. It has been shown that eukaryotic cells are not affected with regard to their growth and normal cell division (i.e.,(i.e., no special cell adhesion to eukaryotic cells). The materials of the invention are therefore not cytotoxic.

[0016] In the application, the "wt%" refers to the total amount of oxides, so the quantities of the glass components are given in "wt% on an oxide basis".

[0017] "Element" is a body that can be made of solid material, but can also be formed with at least one hollow space. The shape of the element according to the invention is freely selectable by a person skilled in the art, depending on the area of ​​application, within the scope of the manufacturing possibilities for glass objects.

[0018] The expert will select the other constituent components or oxides of the glass for the respective application based on their expertise and also with regard to the subsequent application, the combination with other materials (e.g., metals or ceramics), the type of melting, and / or further processing. Refining agents may also be added.

[0019] "Enhancement of human or animal cells" means that the glass is non-cytotoxic to these cells and is hemocompatible with blood. The interaction between the glass surface, with erythrocytes as the main components of blood, and one of the first contact partners after systemic administration was determined by hemolysis and erythrocyte aggregation.

[0020] Cytotoxicity was determined by the inventors with respect to muscle cells, Caco2 cells, and L929 mouse fibroblasts. For this purpose, the glass containing the respective cells was cultured in DMEM (Life Technologies) for 48 hours. The experiments were conducted at 37°C and an atmosphere of +5% CO2. This corresponds to standardized cytotoxicity tests on eukaryotic cells. Cytotoxicity was evaluated based on cell growth and cell morphology. Morphological changes and cell damage were determined qualitatively using digital photographs taken under a light phase-contrast microscope.

[0021] To determine hemolysis and erythrocyte aggregation, human red blood cells were incubated on the respective glassware for two hours at 37°C. The red blood cells were obtained from blood collected in heparinized tubes. The red blood cell suspensions were then used within 24 hours.

[0022] Hemoglobin release was used to quantify any damaging effect of the glass and / or glass-ceramic material on the erythrocyte membrane. Treatment of red blood cells with PBS buffer and a 1% Triton X-100 solution resulted in 0% and 100% hemolysis, respectively. To determine hemolysis, hemoglobin release was determined by spectroscopic analysis of the supernatant at 544 nm. A release of 0 to 2% of the total release was classified as non-hemolytic, a release in the range of 2% to 5% of the total release was classified as slightly hemolytic, and a release of more than 5% of the total release was classified as hemolytic according to the ASTM F756-08 standard.

[0023] To determine erythrocyte aggregation, microscopic images were evaluated by classifying them into three levels. In level 1, the red blood cells remained discretely distributed in the suspension, with no detectable aggregation. In level 2, moderate aggregation with the formation of rouleaux is observed, although the majority of erythrocytes are discrete. This was determined by microscopic observations using a known methodology (see Bauer et al., Macromol. Biosci. 2012, 12, 986-998). In level 3, almost all red blood cells are aggregated into clusters. To determine level 1, the erythrocytes were treated with PBS as a negative control. Positive controls were treated with 30 mg / mL of 25 kDa branched polyethyleneimine and classified as level 3.

[0024] The term "inhibiting the formation of biofilms" means that, compared to glasses and / or glass-ceramics commonly used as substrates for microbial colonization, such as borosilicate glass - for example, "Borofloat 33" by the applicant - or soda-lime glass (Paul Marienfeld GmbH), a smaller area is covered by biofilm when the glass according to the invention is used.

[0025] Biofilm coverage can be determined, for example, by visualization. The inventors conducted corresponding experiments using an LSM510 confocal laser scanning microscope by scanning an area of ​​100 mm (micrometers) by 100 mm (micrometers) on the green channel (480 / 500 nm) and the red channel (490 / 635 nm). A 40 x 10 mm water immersion objective was used. The biofilm images were visualized using ZEN 9.0 software (Carl Zeiss Microscopy GmbH).

[0026] The area covered by biofilm within an image is calculated based on the separation of pixels from the background according to their brightness. A 16-bit image is divided into 256 gray levels (0 = black; 255 = white). By applying an Otsu threshold, all covered areas can be reliably identified. The area covered by biofilm was calculated in relation to the total number of pixels in an image using the imageJ 1.43u software.

[0027] A "glass-ceramic material" is a material made from the same starting materials as glass, but where, during processing before, during, or after shaping, the glass is transformed into a partially crystalline and partially amorphous, i.e., glass-like state, for example, through targeted temperature control. Complete devitrification is also possible.

[0028] A glass-ceramic material is typically understood as a material in which both crystalline and amorphous phases, i.e., glass phases, exist simultaneously. In particular, regions with crystalline phases can be interconnected by glass phases. A glass-ceramic can be considered a partially crystallized glass, in which the degree of crystallization can vary widely, even approaching 100%.

[0029] In an advantageous development of the invention, the glass comprises at least the following components SiO2 in the range of 60 - 75 wt.% R2O in the range of 5 to 20 wt.% RO in the range of 0 to 10 wt.% Al2O3 in the range of 1 to 6 wt.% B2O3 in the range of 0 to 10 wt.% TiO2 in the range of 0 to 8 wt.% ZnO 1 to 7 wt.% FeO 0 to 5 wt.% where R 2 O an oxide or a combination of oxides is selected from the group consisting of Li 2 Oh, well 2 O and K 2 O, and wherein RO is an oxide or a combination of oxides selected from the group comprising MgO and / or CaO and / or BaO and / or SrO. The total amount of R 2 O and / or RO can be formed from one or more oxides of the respective group indicated, in any combination of the oxides.

[0030] Iron oxide is added to the glass in order to melt it using IR emitters or a laser at a wavelength of 1060 nm. The absorption should preferably be between 2 and 20%. This is the case with FeO contents of 2.7 to 5%. The thinner the wall thickness of the glass to be melted, the stronger the absorption should be and thus the higher the FeO content. If the iron is added in the form of Fe 2 O 3 when melting the glass, a suitable melting process must be used to ensure that a sufficient amount of the Fe (III) is reduced to Fe (II) in order to obtain the stated FeO content in the glass. It can be present in the glass in different oxidation states and is stated here as FeO. The person skilled in the art is familiar with converting this into proportions of Fe (III) and Fe 2 O 3 if, for example, they want to state the proportion of Fe 2 O 3 for synthesis purposes.

[0031] In particular, it has proven advantageous if the glass SiO2 in the range of 60 to 70 wt.% R2O in the range of 5 to 20 wt.% RO in the range of 0 to 10 wt.% Al2O3 in the range of 1 to 5 wt.% B2O3 in the range of 0 to 10 wt.% TiO2 in the range of 0 to 8 wt.% ZnO in the range of 1 to 7 wt.% FeO in the range of 0 to 5 wt.% with Na2O in the range of 2 to 10 wt.% and / or K2O in the range of 3.5 to 10 wt.%. comprises, where R 2 O an oxide or a combination of oxides is selected from the group consisting of Li 2 Oh, well 2 O and K 2 O, and wherein RO is an oxide or a combination of oxides selected from the group comprising MgO and / or CaO and / or BaO and / or SrO.

[0032] It is particularly advantageous if the glass is free of CuO, except for impurities. Impurities can generally be present up to a concentration of 0.3%. This means that the CuO content is advantageously between 0 and 0.3%, with 0% being particularly advantageous.

[0033] The described glass is also particularly suitable for producing hermetic feedthroughs, in particular with titanium and / or various titanium alloys. In such a feedthrough, a functional element is usually held by an insulating element in a feedthrough opening of a carrier element, whereby the through opening is hermetically sealed. The carrier element can in particular be a housing and / or a housing part, here in particular a housing or housing component made of titanium or titanium alloys, and the functional element can in particular be a conductor for electrical current. Other functional elements, such as optical fibers, waveguides, hollow guides, tubes, capillaries, etc. are of course also encompassed by the invention. The insulating element is produced from the described material and is, for example, in the form of a plug.

[0034] The suitability of the glass, in particular for the production of feedthroughs with titanium and / or titanium alloys, is based on its chemical compatibility with these metals and / or its thermal expansion coefficient. The thermal expansion coefficient of the glass is particularly advantageously lower than that of titanium and / or the respective titanium alloy, so that a so-called pressure feedthrough can be produced. In such a feedthrough, when the functional element is melted into the carrier element with the aid of the insulation material, the carrier element shrinks onto the insulation element, so that the carrier element exerts a compressive stress on the insulation element, at least at room temperature. This makes it possible, in particular, to reduce the pull-out force, i.e.the force required to push the insulation element out of the carrier element can be significantly increased and / or a reliable and permanently hermetically sealed feedthrough can be provided.

[0035] Particularly good results were achieved with one which SiO2 in the range of 62 to 66 wt.% Al2O3 in the range of 3.8 to 4.5 wt.% B2O3 in the range of 0 to 10 wt.% TiO2 in the range of 3.5 to 4.5 wt.% ZnO in the range of 5 to 7 wt.% FeO in the range of 0.001 to 0.005 wt.% Na2O in the range of 5.9 to 6.5 wt% and K2O in the range of 8.3 to 9.1 wt.% This can contain up to 0.04 wt.% SeO 2 to be available.

[0036] In particular, the glass a proportion of Ag of less than 0.3 wt.% and / or a proportion of P 2 O 5 of less than 0.5 wt.% and / or a proportion of F of less than 1 wt.%. It is particularly advantageous if the proportion of Ag and / or P 2 O 5 is chosen as low as possible, especially if the glass is free of these substances except for impurities. This includes, in particular, the 0% content. This lower limit also applies to F 2. However, it can also be advantageous if a certain small proportion of F 2 are present in the glass. Therefore, an advantageous embodiment provides a proportion of F 2 from more than 0 wt% to less than 1 wt%.

[0037] For applications in the body, the invention provides that the element comprises at least one housing or is a housing which is designed to accommodate active and / or passive electronic components, wherein the housing consists at least partially of the glass and / or glass-ceramic material and / or wherein the housing has at least one layer made of the glass and / or glass-ceramic material on it, at least partially. It is also possible for the housing to additionally be provided with means for administering active substances, for example a membrane and / or a valve, etc. In this way, active substances, in particular medications, can be released into the body and advantageously at a defined location, e.g. directly into the bloodstream.

[0038] The element according to the invention accordingly comprises, in one embodiment, a housing of electronic components or represents such a housing which is formed at least in regions by the glass or on which the glass is applied at least in regions as a layer.

[0039] In a particularly simple embodiment, the housing comprises a glass tube. In particular, the element is a glass tube that is sealed at one or both ends. The element is designed, for example, as a housing for electronic devices such as transponders or entire defibrillators, pacemakers, labs-on-chip, or contact lenses.

[0040] The disclosure further provides a glass and / or glass-ceramic and / or ceramic material for use as a biofilm-inhibiting and / or antibacterial element and / or a biofilm-inhibiting and / or antibacterial region of an element and / or a biofilm-inhibiting and / or antibacterial layer on or in an element that can be introduced into or attached to the human or animal body, wherein the glass and / or glass-ceramic and / or ceramic material SiO2 in the range of 60 to 75 wt% and ZnO in the range of 1 to 7 wt.% This includes, in particular, an element described above.

[0041] Furthermore, the disclosure relates to the use of a glass and / or glass-ceramic and / or ceramic material described above for producing an element that can be introduced into the human or animal body, in particular an element that can be implanted into the human or animal body, or for producing an element that can be attached to the human or animal body. In a preferred embodiment, the disclosure relates to a glass and / or glass-ceramic material described above for producing implants, hermetic feedthroughs, vascular supports, in particular stents, catheters, artificial heart valves, housings for electronic devices such as transponders or entire defibrillators, pacemakers or labs-on-chip, as well as contact lenses and / or coatings on contact lenses, wherein when used as contact lenses and / or coatings on contact lenses, the content of coloring substances, e.g.Iron oxide and other impurities should be as low as possible.

[0042] The use of glass as a transponder material has proven particularly advantageous compared to known materials for this application. Transponder material is used, for example, for the hermetic encapsulation of RFID transponders, which are used, for example, for the identification and tracking of pets and livestock. Encapsulation with the described material enables the protection of the electronic component within the body, while simultaneously protecting the surrounding tissue from the electronics located inside the encapsulation. Furthermore, it offers protection from environmental influences such as moisture and dirt when the transponder is worn on the body. Here, the inhibitory effect of the material according to the invention against the formation of biofilms also proves advantageous. This also applies to medical devices worn on the body, such as contact lenses.

[0043] However, the transponders can also be implanted, and in this application, the particularly good compatibility of the material according to the invention with human or animal cells comes into play. This also applies to the use of the glass as a housing or housing component for another electronic medical device, for example, an active implant, and for applications as a material for a medical device inserted into the body, such as implants, vascular supports, in particular stents, and catheters, artificial heart valves, dosing devices for active substances, and the like, as well as combinations of the aforementioned items.

[0044] The element according to the invention is suitable in connection with all medical devices or aids such as cannulas, suture material, also clamps, and the like, which are used on or in the body.

[0045] The invention will be explained in more detail below with reference to the accompanying drawings using exemplary embodiments. Identical and similar components are provided with the same reference numerals, whereby the features of the various exemplary embodiments can be combined and / or interchanged.

[0046] They show: Figure 1 Analysis and visualization of biofilm growth after cultivation for 24 hours: Approximate data analysis of biofilm-covered area, cumulative for all bacteria, Figure 2 Analysis and visualization of biofilm growth after cultivation for 24 hours: Quantitative analysis of biofilm-covered area according to bacterial species, Figure 3 Analysis and visualization of biofilm growth after cultivation for 24 hours: Representative images of biofilms on soda-lime glass, Figure 4 Analysis and visualization of biofilm growth after cultivation for 24 hours: Representative images of biofilms on glass according to a first embodiment of the invention, Figure 5 Cytotoxicity and hemocompatibility of soda-lime glass and various borosilicate glasses: Representative images of cultured muscle cells, Caco2 cells and L929 mouse cells.Figure 6 Cytotoxicity and hemocompatibility of soda-lime glass and various borosilicate glasses: data on hemolysis, Figure 7 Cytotoxicity and hemocompatibility of soda-lime glass and various borosilicate glasses: data on erythrocyte aggregation, Figure 8 Cytotoxicity and hemocompatibility of soda-lime glass and various borosilicate glasses: representative images of cultured cells of MSSA, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Klebsiella pneumonia, Pseudomonas aeruginosa, Proteus Mirabilis, Staphylococcus epidermis, Figure 9 Schematic representations of an implantable housing for an electronic component according to a first embodiment of the invention, Figure 10 A schematic representation of a vascular support according to a further embodiment of the invention.

[0047] To investigate the inhibition of biofilm growth and the growth of human and animal cells, experiments were conducted with different glasses. Glasses "BF1" and "BF2" were used as embodiments of the invention. Glasses "VG1", "VG2", and "VG3" were investigated as comparative examples.

[0048] The following Table 1 provides an overview of the chemical composition of the glasses and glass ceramics examined: Proportion (wt%) VG1 VG2 VG3 BF1 BF2 SiO2 72,48 81,19 61,59 63,03 63,06 Al2O3 1,21 2,41 16,96 4,11 4,11 Na2O 14,36 3,52 12,32 6,08 6,08 K2O 1,21 0,08 4,14 8,51 8,51 MgO 4,32 0,00 3,94 0,00 0,00 CaO 6,43 0,00 0,00 0,00 0,00 ZnO 0,00 0,00 0,00 5,83 5,83 B2O3 0,00 12,76 0,00 8,22 8,22 CeO2 0,00 0,00 0,30 0,00 0,00 TiO2 0,00 0,00 0,00 3,98 4,11 SnO2 0,00 0,00 0,40 0,00 0,00 Sb 2 O 3 0,00 0,00 0,00 0,20 0,00 F 2 0,00 0,00 0,30 0,00 0,000 FeO 0,01 0,04 0,05 0,05 0,05 SeO 2 0,00 0,00 0,00 0,00 0,03 sum 100,00 100,00 100,00 100,00 100,00

[0049] The glasses were tested in the form of plates. The plates were first ultrasonically cleaned in 1% Deconex 12 PA (Borer advanced cleaning solutions) at 40°C for 15 minutes. The reagent was first removed with warm tap water and then washed with deionized water. The plates were then ultrasonically treated in deionized water at 40°C for 5 minutes. Finally, the plates were dried in a nitrogen stream.

[0050] For the biofilm formation tests, eight typical representatives of nosocomial infections were examined, namely MSSA: Staphylococcus aureus, methicillin-sensitive (ATCC 29213) Staphylococcus epidermis (Pp 62a) Enterococcus faecalis (ATCC 29212) Enterococcus faecium (SMZ 20477) Escherichia coli (ATCC 25922) Klebsiella pneumonia (ATCC 700603) Pseudomonas aeruginosa (PA01) Proteus Mirabilis (VBK 4479).

[0051] The bacterial mother cultures were stored at -80°C in 10 vol% glycerol solution. Before cultivation in liquid medium, a strand of frozen bacteria was streaked onto lysogeny broth (LB) agar (1.5%) plates and incubated overnight at 37°C. A single colony of each of the human pathogenic strains was cultured overnight in Mueller-Hinton (MH) medium at 37°C.

[0052] For biofilm formation, the cultures were freshly inoculated into MH medium at a dilution of 1:1000 and placed into 8 x 2 sections of the silicone mounts (SCHOTT Nexterion) attached to the glass plates. Biofilms were grown at 37°C for 24 hours without shaking.

[0053] The biofilms were stained using the LIVE / DEAD BacLight Bacterial Viability Kit (Life Technologies). After staining, the bacterial supernatant was carefully removed and the biofilms were gently washed once with 300 They were then washed with 1 L (microliter) of a 0.9% NaCl solution. They were then embedded in Fluoromount-G (SouthernBiotech, BIOZOL) and covered with Nexterion(R) glass coverslips (SCHOTT Nexterion). The biofilms were visualized as described above.

[0054] In the Figures 1 to 4 The results of the analysis and visualization of biofilm growth after 24 hours of cultivation are shown. The symbol p stands for the "p-value" or significance value and is a key figure for evaluating statistical tests. In the life sciences, a threshold of 5% has been established (maximum probability of error or significance level α = 0.05). This means: If the probability that a result occurred by chance is less than 5%, it is considered "significant" (p < 0.05).

[0055] The statistical analysis of the biofilm-covered areas (cumulative for all species) is presented in Table 2 below. N denotes the number of experiments and SEM the standard error of mean. Glass type Biofilm area (%) Biofilm thickness (µm) Degree of biofilm homogeneity (% incomplete) mean SEM VG1 (N=24) 69,33 7,041 10 to 30 <10 VG2 (N=27) 21,03 1,500 10 to 30 < 20 VG3 (N=25) 14,32 1,875 10 to 30 < 50 BF1 (N=27) 0,76 0,294 4 to 10 > 95 BF2 (N=25) 0,07 0,026 4 to 10 > 95

[0056] All human pathogenic strains tested grew well on the surfaces of the glass corresponding to VG1, as well as on the plates with the composition of VG2 and VG3. After 24 hours, most of the bacteria were alive, as evidenced by the green staining with SYTO9. The sporadic dead cells (stained red by propidium iodide) correspond to the usual decrease in biofilms.

[0057] On the BF1 and BF2 slides, all human pathogens tested showed reduced biofilm formation. Biofilm thickness is significantly reduced and lies between 4 m and 10 m (micrometers). Furthermore, the biofilms on the glasses according to the invention exhibit morphological changes with diffuse and porous structures. The total areas covered by biofilm, 0.76 + / - 0.294% and 0.07 + / - 0.026%, respectively, are significantly reduced compared to the other glasses tested. Furthermore, the biofilms present on the glasses according to the invention exhibit a significantly increased porosity of over 95% compared to the other glasses tested. Like the well-grown biofilms on VG1, VG2, and VG3, the reduced biofilms exhibit only a small number of dead cells.

[0058] These results surprisingly suggest that the chemical composition of the inventive materials BF1 and BF2 prevents the initial step of bacterial adhesion. Previously, the inventive glasses tested had been used as resistant covers for touch panels in automotive navigation systems, substrates for capacitive sensors, filters for camera modules in mobile phones, and as housings for CCD image sensors. Therefore, a person skilled in the field of microbiology had no contact with these glasses.

[0059] In the Figures 5 to 8 Results on the in vitro determined cytotoxicity and hemocompatibility of soda-lime glass and various borosilicate glasses are presented.

[0060] To evaluate changes in cell morphology and growth performance, muscle cells, Caco2 cells, and L929 mouse fibroblasts were cultured on the different glassware for 48 hours. Compared to control cells in cell culture flasks, no changes in cell morphology or growth performance were found for any of the glassware. As the images in Figure 5 As shown, no apoptotic cells or abnormalities were found in the cell environment. None of the glass compositions tested showed any signs of cytotoxicity.

[0061] To investigate hemolysis, erythrocytes were incubated on the glass surfaces for two hours. Figure 6As demonstrated by the results plotted, regardless of glass composition, none of the glasses exhibited hemolysis levels greater than 0.57%. According to ASTM Standard F756-00, a hemoglobin release between 0 and 2% is considered non-hemolytic. This indicates no detectable disruption of the red blood cell membranes.

[0062] Additionally, the ability of the materials to induce erythrocyte aggregation was investigated. Erythrocyte aggregation is an undesirable phenomenon that leads to adverse effects on the circulatory system and even fatal toxicity. Erythrocyte aggregation was visualized microscopically after two hours of incubation on the glass surfaces. Treatment with 25 kDa bPEI at 30 mg / mL as a positive control resulted in the formation of aggregates (level 3 according to the classification explained above). Figure 7However, as shown, no red blood cell aggregation was observed for any of the materials tested. Furthermore, all glass compositions demonstrated very good hemocompatibility.

[0063] Of the bacteria used, S. epidermis showed a low tendency to form biofilms on the glass. K. pneumonia and MSSA, on the other hand, showed an increased tendency to adhere and grow on the glass surfaces, as shown in the images in Figure 8 However, even for these germs, biofilm formation on the glasses according to the invention is significantly reduced.

[0064] Glasses and / or glass-ceramics and / or ceramics with the composition according to the invention are therefore particularly suitable for the development of highly effective anti-biofilm surfaces or coatings. Compared to Comparative Examples VG1 to VG3, the glass and / or glass-ceramic and / or ceramic material according to the invention exhibits reduced biofilm adhesion, increased biofilm porosity, and reduced biofilm thickness. Furthermore, they are excellently cyto- and hemocompatible without being toxic to eukaryotic cells.

[0065] These surprising properties open up a variety of possible applications for the invention in the field of medicine.

[0066] In the Figures 9 and 10 exemplary applications for the glass or for a glass-ceramic material are shown.

[0067] In Figure 9A housing 1 for electronic components 2 is shown. Housings for transponders, so-called transponder tubes, are simply manufactured as sections of tubes. For example, one end is then sealed by melting. Such a housing for a transponder is shown in Figure 9 shown above under A). Through the still open end - visible on the right side of the illustration - an electronic component, called a "transponder", is then inserted into the tube, compare Figure 9 B) The "transponder" can be, for example, an RFID chip or a sensor. Using heat, such as laser and / or infrared radiation, the still open end of the tube can then be sealed. The housing is then advantageously hermetically sealed, as in Figure 9 C) shown. In a preferred embodiment of the invention, the housing is autoclavable.

[0068] The proportion of FeO in the glass can promote the sealing of the tube, particularly through the application of laser and / or infrared radiation, in particular because this increases the absorption of the material in the infrared spectral range.

[0069] Typical dimensions for such transponder housings are outer diameters in the range of up to 10 mm, preferably in the range of up to 5 mm, particularly preferably in the range between 1 mm and 4 mm, and lengths in the range of up to 100 mm, preferably in the range of up to 70 mm, particularly preferably in the range between 5 mm and 50 mm. The wall thickness is in particular in the range of up to 2 mm, preferably in the range of up to 1.5 mm, particularly preferably in the range between 0.03 mm and 1.1 mm.

[0070] It is also possible for the element, which is shaped, for example, as a tubular section, to be provided on at least one side with a device permeable to an active ingredient, such as a membrane, and for the interior to be filled with an active ingredient. In this way, an implant for administering active ingredients can be easily produced.

[0071] It is also possible to integrate electronic elements into such an implant for administering active substances, wherein the electronic element can in particular control and / or trigger the conditions of the active substance release, in particular the time and / or the amount of the active substance release. This electronic element can in particular also be designed such that it can communicate with electronic devices outside the body by means of electrical conductors, e.g. wires and / or contacts, but also by wireless communication, which can in particular transmit control and / or sensor signals to the electronic element within the implant. Thus, the described implant can be part of a more complex diagnostic and / or treatment apparatus.

[0072] Similarly, it is possible for substances, especially liquids, from the human or animal body to pass through the permeable device into the interior of the implant and then be analyzed by the device and / or electronic elements. Data obtained from the analysis can be transmitted to electronic devices outside the human or animal body.

[0073] In Figure 10A stent 3 is shown as a further possible application of the glass. The stent 3 is inserted into a hollow organ 4, for example a blood vessel. The stent 3 is made of a metal mesh, for example of titanium. The enlargement of section A on the right-hand side of the figure shows a section of a metal filament 5 of the metal mesh. According to the invention, the metal filaments 5 have, at least in some regions, a coating 6 made of the glass and / or glass-ceramic material according to a composition described above. This significantly reduces the susceptibility of the stent 3 to colonization by known materials. In addition, a stent coated in this way is very well tolerated by the human or animal body.

Claims

1. An element (1; 3) introducible into a human or animal body, wherein the element is selected from the group consisting of casings for electronic devices such as transponders, defibrillators, pacemakers, and wherein the element comprises a glass at least in some areas thereof, which inhibits the formation of biofilms, and / or which is not cytotoxic to human or animal cells and is compatible with blood, when the element is introduced into the human or animal body or attached thereto; wherein the glass comprises at least: SiO2 in a range from 60 to 75 wt%, and ZnO in a range from 1 to 7 wt%; characterized in that the element comprises at least one casing (1) or constitutes a casing (1) adapted for accommodating electronic components (2); wherein the casing is made of said glass at least in areas thereof; and / or wherein the casing has at least one coating made of said glass at least in areas thereof.

2. The element (1; 3) according to claim 1, wherein the glass comprises at least the following components: SiO2in a range from 60 to 75 wt%R2Oin a range from 5 to 20 wt%ROin a range from 0 to 10 wt%Al2O3in a range from 1 to 6 wt%B2O3in a range from 0 to 10 wt%TiO2in a range from 0 to 8 wt%ZnO1 to 7 wt%FeO0 to 5 wt%; wherein R2O is an oxide or a combination of oxides selected from the group consisting of Li2O, Na2O and K2O; and wherein RO is an oxide or a combination of oxides selected from the group consisting of MgO and / or CaO and / or BaO and / or SrO.

3. The element (1; 3) according to claim 1 or 2, wherein the glass comprises SiO2in a range from 60 to 70 wt%R2Oin a range from 5 to 20 wt%ROin a range from 0 to 10 wt%Al2O3in a range from 1 to 5 wt%B2O3in a range from 0 to 10 wt%TiO2in a range from 0 to 8 wt%ZnOin a range from 1 to 7 wt%FeOin a range from 0 to 5 wt%;withNa2Oin a range from 2 to 10 wt%; and / orK2Oin a range from 3.5 to 10 wt%; wherein R2O is an oxide or a combination of oxides selected from the group consisting of Li2O, Na2O and K2O; and wherein RO is an oxide or a combination of oxides selected from the group consisting of MgO and / or CaO and / or BaO and / or SrO.

4. The element (1; 3) according to any one of the preceding claims, characterized in that the glass comprises a content of Ag of less than 0.3 wt%; and / or a content of P2O5 of less than 0.5 wt%; and / or a content of F of less than 1 wt%.

5. The element (1) according to any one of the preceding claims, characterized in that the casing comprises or is formed from a tube made of said glass.

6. The element (1) according to any one of claims 1 to 4, wherein the casing is made from Ti and / or a titanium alloy and comprises an insulating element which is made from said glass in a feedthrough opening of the casing.